Granulomatosis with Polyangiitis Drug and Forecast Market

List of Tables
Table 1. Key Players of Granulomatosis with Polyangiitis Drug in Global Market
Table 2. Top Granulomatosis with Polyangiitis Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Granulomatosis with Polyangiitis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Granulomatosis with Polyangiitis Drug Revenue Share by Companies, 2017-2022
Table 5. Global Granulomatosis with Polyangiitis Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Granulomatosis with Polyangiitis Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Granulomatosis with Polyangiitis Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Granulomatosis with Polyangiitis Drug Product Type
Table 9. List of Global Tier 1 Granulomatosis with Polyangiitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Granulomatosis with Polyangiitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Granulomatosis with Polyangiitis Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Granulomatosis with Polyangiitis Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Sales, (K Pcs), 2023-2028
Table 46. Bionovis SA Corporate Summary
Table 47. Bionovis SA Granulomatosis with Polyangiitis Drug Product Offerings
Table 48. Bionovis SA Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Bristol-Myers Squibb Company Corporate Summary
Table 50. Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Product Offerings
Table 51. Bristol-Myers Squibb Company Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. ChemoCentryx Inc Corporate Summary
Table 53. ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Product Offerings
Table 54. ChemoCentryx Inc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Coherus BioSciences Inc Corporate Summary
Table 56. Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Product Offerings
Table 57. Coherus BioSciences Inc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Genor BioPharma Co Ltd Corporate Summary
Table 59. Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Product Offerings
Table 60. Genor BioPharma Co Ltd Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. GlaxoSmithKline Plc Corporate Summary
Table 62. GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Product Offerings
Table 63. GlaxoSmithKline Plc Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Iltoo Pharma Corporate Summary
Table 65. Iltoo Pharma Granulomatosis with Polyangiitis Drug Product Offerings
Table 66. Iltoo Pharma Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Panacea Biotec Ltd Corporate Summary
Table 68. Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Product Offerings
Table 69. Panacea Biotec Ltd Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Sandoz International GmbH Corporate Summary
Table 71. Sandoz International GmbH Granulomatosis with Polyangiitis Drug Product Offerings
Table 72. Sandoz International GmbH Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. The International Biotechnology Center (IBC) Generium Corporate Summary
Table 74. The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Product Offerings
Table 75. The International Biotechnology Center (IBC) Generium Granulomatosis with Polyangiitis Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Granulomatosis with Polyangiitis Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 77. Global Granulomatosis with Polyangiitis Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Granulomatosis with Polyangiitis Drug Production by Region, 2017-2022 (K Pcs)
Table 79. Global Granulomatosis with Polyangiitis Drug Production by Region, 2023-2028 (K Pcs)
Table 80. Granulomatosis with Polyangiitis Drug Market Opportunities & Trends in Global Market
Table 81. Granulomatosis with Polyangiitis Drug Market Drivers in Global Market
Table 82. Granulomatosis with Polyangiitis Drug Market Restraints in Global Market
Table 83. Granulomatosis with Polyangiitis Drug Raw Materials
Table 84. Granulomatosis with Polyangiitis Drug Raw Materials Suppliers in Global Market
Table 85. Typical Granulomatosis with Polyangiitis Drug Downstream
Table 86. Granulomatosis with Polyangiitis Drug Downstream Clients in Global Market
Table 87. Granulomatosis with Polyangiitis Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Granulomatosis with Polyangiitis Drug Segment by Type
Figure 2. Granulomatosis with Polyangiitis Drug Segment by Application
Figure 3. Global Granulomatosis with Polyangiitis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Granulomatosis with Polyangiitis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Granulomatosis with Polyangiitis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Granulomatosis with Polyangiitis Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Granulomatosis with Polyangiitis Drug Revenue in 2021
Figure 9. By Type - Global Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Granulomatosis with Polyangiitis Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Granulomatosis with Polyangiitis Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 19. US Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 24. Germany Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 33. China Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 40. Brazil Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Granulomatosis with Polyangiitis Drug Sales Market Share, 2017-2028
Figure 44. Turkey Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Granulomatosis with Polyangiitis Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Granulomatosis with Polyangiitis Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Granulomatosis with Polyangiitis Drug by Region, 2021 VS 2028
Figure 50. Granulomatosis with Polyangiitis Drug Industry Value Chain
Figure 51. Marketing Channels